Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
BMJ Open Quality|August 2, 2023
Improving outpatient clinic experience: the future of chronic kidney disease care and associated multimorbiditySaif Al-Chalabi, Helen Alderson, Natalie Garratt, et al.
BMC Nephrology|December 10, 2023
The epidemiology of primary FSGS including cluster analysis over a 20-year periodThomas McDonnell, Joshua Storrar, Rajkumar Chinnadurai, et al.
Family Practice|May 3, 2018
Improved management of acute kidney injury in primary care using e-alerts and an educational outreach programmeJames Tollitt, Emma Flanagan, Sheila McCorkindale, et al.
Plos One|October 13, 2022
A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decadesJoshua Storrar, Tarra Gill-Taylor, Rajkumar Chinnadurai, et al.
BMJ Case Reports|June 21, 2011
Small bowel angiodysplasia in a patient on haemodialysis: difficulties in diagnosis and managementSmeeta Sinha, Jessica L R Williams, Helen Eddington, et al.
BMC Medical Informatics and Decision Making|February 14, 2018
Presentation of laboratory test results in patient portals: influence of interface design on risk interpretation and visual search behaviourPaolo Fraccaro, Markel Vigo, Panagiotis Balatsoukas, et al.
Nephron. Clinical Practice|May 15, 2009
Factors associated with vascular stiffness: cross-sectional analysis from the Chronic Renal Insufficiency Standards Implementation StudyHelen Eddington, Smeeta Sinha, Elizabeth Li, et al.
Kidney International Reports|December 11, 2020
Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis - Subgroup Analyses of the CALIPSO TrialPaolo Raggi, Antonio Bellasi, Smeeta Sinha, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 9, 2021
Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis: An Analysis of the Randomized, Placebo-Controlled CaLIPSO StudyDavid A Bushinsky, Paolo Raggi, Jordi Bover, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 29, 2022
Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think DifferentlyMarc Evans, Angharad R Morgan, Stephen C Bain, et al.
Pageof 10